Last quarter (Q2 2025), VistaGen Therapeutics's total revenue was $200.00K, a decrease of -27.98% from the same quarter last year. In Q2, VistaGen Therapeutics's net income was $-12.96M. See VistaGen Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Total Revenue	$ 908.70K	$ 1.06M	$ -227.00K	$ 1.11M	$ 1.09M	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ 908.70K	$ 1.06M	$ -227.00K	$ 1.11M	$ 1.09M	$ ―
Operating Expense	$ 46.48M	$ 34.09M	$ 59.04M	$ 48.89M	$ 19.02M	$ 20.80M
Operating Income	$ -45.60M	$ -33.02M	$ -59.27M	$ -47.78M	$ -17.93M	$ -20.80M
Net Non Operating Interest Income Expense	$ 5.73M	$ 3.35M	$ 26.00K	$ -20.00K	$ 1.60K	$ 30.10K
Other Income Expense	$ -312.00K	$ -312.00K	$ 77.40K	$ -232.00K	$ -600.00	$ ―
Pretax Income	$ -39.56M	$ -29.36M	$ -59.24M	$ -47.76M	$ -17.93M	$ -20.77M
Tax Provision	$ 8.50K	$ 4.00K	$ 6.00K	$ 3.40K	$ 2.60K	$ 2.60K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -39.57M	$ -29.36M	$ -59.25M	$ -48.71M	$ -42.32M	$ -22.04M
Basic EPS	$ -0.69	$ -1.52	$ -8.51	$ -7.50	$ -14.70	$ -15.00
Diluted EPS	$ -0.69	$ -1.52	$ -8.51	$ -7.50	$ -14.70	$ -15.00
Basic Average Shares	$ 121.23M	$ 19.35M	$ 6.96M	$ 6.60M	$ 2.87M	$ 1.46M
Diluted Average Shares	$ 121.23M	$ 19.35M	$ 6.96M	$ 6.60M	$ 2.87M	$ 1.46M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 46.48M	$ 34.09M	$ 59.04M	$ 48.66M	$ 19.02M	$ 20.80M
Net Income From Continuing And Discontinued Operation	$ -39.57M	$ -29.36M	$ -59.25M	$ -47.76M	$ -17.93M	$ -20.77M
Normalized Income	$ -39.16M	$ -29.06M	$ ―	$ ―	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -42.93M	$ -33.02M	$ -59.27M	$ -47.76M	$ -17.92M	$ -20.80M
EBITDA	$ -42.33M	$ -32.45M	$ -58.74M	$ -47.05M	$ -17.44M	$ -20.26M

Currency in USD

VistaGen Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing